News and Trends 7 May 2025 Top biotech deals of April 2025 Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and drug delivery. May 7, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 2 Apr 2025 Top biotech deals of March 2025 Learn about the top biotech deals of March 2025. Small molecules, bispecific antibodies, and protein therapies were all part of major collaborations. April 2, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Mar 2025 Top biotech deals of February 2025 Find out about the top biotech partnership deal of February 2025. Small molecules, T-cell engagers, and RNA medicines, were all part of major collaborations. March 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 24 Feb 2025 Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree? This year has seen Eli Lilly sign several licensing deals to bolster its position across a range of therapeutic areas amid growing drug revenues. February 24, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 19 Feb 2025 Trade war: how new U.S. tariffs will impact the biopharma industry The U.S. plans to impose trade tariffs on imports. How does this affect the biopharma industry? February 19, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Feb 2025 Top biotech deals of January 2025 January 2025 kicked off in full swing with several biotech deals in the biopharma industry. February 6, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jan 2025 U.K. biotech defies the odds, raising £3.5B in 2024 The U.K. biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report. January 31, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 20 Jan 2025 Is biotech M&A set to surge in 2025? There is big hope for biotech M&A in 2025, with a resounding sense that activity will rise again as several important factors come into play. January 20, 2025 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jan 2025 Top biotech deals of December 2024 The month of December saw a variety of biotech deals take place to advance therapies across different stages in development. January 16, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 13 Jan 2025 2025 predictions: Which trends are set to shape the biotech industry this year? From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech industry in 2025. January 13, 2025 - 18 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Reports Produced by Inpart 7 Jan 2025Partnering 2030: Biopharma Report Download Inpart’s latest report to hear from biotechs and out-licensors, following this year’s Partnering 2030 survey. The report includes real-world partnering experiences, challenges, and insights into working with top pharmaceutical firms. January 7, 2025 Share WhatsApp Twitter Linkedin Email Produced by Inpart
News and Trends 2 Jan 2025 A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development Last month saw a number of alliances forming in a range of therapeutic spaces but there has been one serial collaborator that stands out – GSK. January 2, 2025 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email